| Product Name | Docetaxel-d9 |
| Product Code | DA-D238-03 |
| Chemical name | Docetaxel-d9 |
| Synonyms | (αR,βS)-β-[[(1,1-Dimethylethoxy-d9)carbonyl]amino]-α-hydroxybenzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy) -2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester; Docetaxol-d9; N-Debenzoyl-N-(tert-butoxycarbonyl-d9)-10-deacetyltaxol; RP 56976-d9; Taxotere-d9; |
| Impurity | NA |
| CAS Number | 940867-25-4 |
| Alternate CAS # | NA |
| Molecular form | C43H44D9NO14 |
| Appearance | White to Off-White Solid |
| Melting Point | NA |
| Mol. Weight | 816.93 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | chiral standards,enzyme inhibitors,pharmaceutical standards,intermediates,fine chemicals,stable isotopes |
| Boiling Point | NA |
| Applications | A labelled semisynthetic derivative of Paclitaxel. An antimitotic agent that promotes the assembly of micro-tubules and inhibits their de-polymerization to free tubulin. An antineoplastic. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
